Medical robotics takes centre stage at Cambridge Network Business Lecture

It features Founders and CEOs from Network members Cambridge Medical Robotics and Cambridge Bio-Augmentation Systems, both of which use robotics, but for two very different aspects of medical treatment. Cambridge Medical Robotics uses next generation robots for minimal access surgery, while Cambridge Bio-Augmentation Systems focuses on bionics for amputees.

Martin Frost, CEO of Cambridge Medical Robotics (CMR) will talk about how the company is developing the world’s smallest, next-generation universal robotic system for minimal access surgery which looks set to transform the existing market for surgical robotics. Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025 (Industry Forecast, Accuray Research). Cambridge Medical Robotics has grown rapidly since incorporation in 2014, employing its 100th employee this summer, six months ahead of schedule.

Other speakers will be Oliver Armitage and Emil Hewage from Cambridge Bio-Augmentation Systems (CBAS). Founded in 2015, CBAS is developing the platform technology for the future of bionics, standardising the connection between machines and the human nervous system for medical application. This means that amputees should be able to benefit from improved artificial limb movement while clinicians will be able to access real-time feedback on the biomechanics of their patients. Today, their tech is being trialled for advanced limbs, bioelectronic medicines and bionic organs.

Central to the event, as always, is the opportunity for networking both before and after the presentations. The event at the Hauser Forum (The Entrepreneurship Centre, 3 Charles Babbage Road, CB3 0GT) - open to all - begins at 6pm and will close by 8.30pm.

Please follow the instructions to sign up here